Inactive Instrument

Press Releases Salix Pharmaceuticals, Ltd.

Equities

US7954351067

Press Releases

Unlock all the news: Be the first to know and act before the market!

Salix Pharmaceuticals : Confirms Receipt of an Unsolicited Proposal from Endo International plc	15-03-11	BU
Salix Pharmaceuticals : Reports 4Q2014 and FY2014 Results	15-03-02	BU
Salix Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover	15-02-27	PR
Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 1.5% Convertible Senior Notes Due 2019	15-02-25	BU
Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 2.75% Convertible Senior Notes Due 2015	15-02-25	BU
Salix Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Salix Pharmaceuticals Ltd.	15-02-24	PR
Salix Pharmaceuticals : Announces 4Q and FY2014 Financial Results Conference Call and Webcast	15-02-16	BU
Salix Pharmaceuticals : Announces the Promotion of William P. Forbes, PharmD to President, Medical, R&D and Chief Development Officer	15-02-02	BU
Salix Pharmaceuticals : Federman & Sherwood : Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws	15-01-30	BU
Salix Pharmaceuticals : Provides Update on Audit Committee Review	15-01-28	BU
Salix Pharmaceuticals : The Shuman Law Firm : Investigates Salix Pharmaceuticals Ltd.	15-01-09	BU
Salix Pharmaceuticals : Carolyn Logan to Retire as Chief Executive Officer of Salix Pharmaceuticals	15-01-05	BU
Salix Pharmaceuticals : INVESTOR ALERT: Investors of Salix Pharmaceuticals, Ltd. with Losses of $100,000 or More Are Encouraged to Contact Law Offices of Howard G. Smith	15-01-02	BU
Salix Pharmaceuticals : Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of January 6, 2015 Lead Plaintiff Deadline in Class Litigation - SLXP	14-12-17	BU
Salix Pharmaceuticals : Provides Updates on Wholesaler Inventory Reductions and the XIFAXAN® 550 for IBS-D Approval Timeline, and Provides Preliminary Guidance for 2015 and 2016	14-12-16	BU
Salix Pharmaceuticals : Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of Upcoming Deadline in Class Action Litigation - SLXP	14-12-10	BU
Salix Pharmaceuticals : Announces Plan to Augment Board of Directors	14-11-24	BU
Salix Pharmaceuticals : INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO	14-11-07	BU
Salix Pharmaceuticals : Harwood Feffer LLP : Announces Investigation of Salix Pharmaceuticals Ltd.	14-11-07	PR
Salix Pharmaceuticals : Federman & Sherwood : Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws	14-11-07	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Salix Pharmaceuticals, Ltd.

Equities

US7954351067

Press Releases

Filters